Telix Pharmaceuticals Ltd has released a press release.
Telix Investor Day Presentation
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
In the deck
Earlier from Telix Pharmaceuticals
- Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan
- Telix to Host Investor Day in New York City on June 11, 2025
- Telix at ANZSNM Annual Scientific Meeting 2025
- Illuccix China Phase 3 Study Completes Enrolment
- Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
Later from Telix Pharmaceuticals
- Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
- Telix Precision Medicine Announces AlFluor Radiochemistry Platform
- Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
- Gozellix Receives Permanent HCPCS Code
- Telix Reports US$204M Q2 Revenue, Up 63% YOY
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals